TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
117,207
|
102,436
|
132,749 |
Financial expenses |
615
|
280
|
157 |
Earnings before taxes |
7,831
|
6,234
|
6,045 |
EBITDA |
8,714
|
6,585
|
6,722 |
Total assets |
60,986
|
61,228
|
63,645 |
Current assets |
40,255
|
42,462
|
42,688 |
Current liabilities |
19,022
|
31,837
|
28,938 |
Equity capital |
30,140
|
27,485
|
32,029 |
- share capital |
772
|
768
|
836 |
Employees (average) |
14
|
15
|
16 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
49.4%
|
44.9%
|
50.3% |
Turnover per employee |
8,372
|
6,829
|
8,297 |
Profit as a percentage of turnover |
6.7%
|
6.1%
|
4.6% |
Return on assets (ROA) |
13.8%
|
10.6%
|
9.7% |
Current ratio |
211.6%
|
133.4%
|
147.5% |
Return on equity (ROE) |
26.0%
|
22.7%
|
18.9% |
Change turnover |
14,243
|
-19,560
|
-14,828 |
Change turnover % |
14%
|
-16%
|
-10% |
Chg. No. of employees |
-1
![]() |
-1
|
-4 |
Chg. No. of employees % |
-7%
|
-6%
|
-20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.